The table below shows PHIBRO ANIMAL HEALTH CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
$833.35M
$800.35M
Cost of revenue
$896.27M
$704.59M
$679.65M
$656.86M
$561.97M
$543.47M
Gross profit
$399.94M
$313.09M
$298.24M
$285.40M
$271.38M
$256.88M
R&D
$23.73M
$29.19M
$24.39M
$20.83M
$17.76M
$13.74M
PAHC annual revenue (10-K history)
PHIBRO ANIMAL HEALTH CORP reported annual revenue of $1.30B for fiscal year 2025. That is up 27.4% from $1.02B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $751.53M (FY 2016) to $1.30B. Figures come from the company's audited annual reports as filed with the SEC.